Phase II trial of single agent amrubicin (A) in patients (pts) with previously treated advanced thymic malignancies (TM).

被引：0
|
作者：
Wakelee, Heather A.
Padda, Sukhmani Kaur
Burns, Matthew
Spittler, Aaron John
Riess, Jonathan
San Pedro-Salcedo, Melanie
Ramchandran, Kavitha
Gubens, Matthew A.
Neal, Joel W.
Loehrer, Patrick J.
机构：
[1] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA
[2] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA
[3] Univ Calif Davis, Ctr Comprehens Canc, Sacramento, CA 95817 USA
[4] UC San Francisco, San Francisco, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7580
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II Trial of Single Agent Amrubicin in Patients with Previously Treated Advanced Thymic Malignancies
    Wakelee, Heather A.
    Padda, Sukhmani K.
    Burns, Matthew
    Spittler, A. J.
    Riess, Jonathan W.
    San Pedro-Salcedo, Melanie
    Ramchandran, Kavitha J.
    Gubens, Matthew A.
    Neal, Joel W.
    Loehrer, Patrick J.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S195 - S195
  • [2] Phase II trial of single agent amrubicin in patients with previously treated advanced thymic malignancies
    Hellyer, Jessica A.
    Gubens, Matthew A.
    Cunanan, Kristen M.
    Padda, Sukhmani K.
    Burns, Matthew
    Spittler, A. John
    Riess, Jonathan W.
    San Pedro-Salcedo, Melanie
    Ramchandran, Kavitha J.
    Neal, Joel W.
    Wakelee, Heather A.
    Loehrer, Patrick J., Sr.
    LUNG CANCER, 2019, 137 : 71 - 75
  • [3] Phase II trial of amrubicin in patients with previously treated advanced thymic malignancies
    不详
    JOURNAL OF THORACIC DISEASE, 2015, 7
  • [4] STAGE 1 RESULTS OF A 2-STAGE PHASE II TRIAL OF SINGLE AGENT AMRUBICIN IN PATIENTS WITH PREVIOUSLY TREATED THYMIC MALIGNANCIES
    Wakelee, Heather A.
    Riess, Jonathan W.
    San Pedro-Salcedo, Melanie
    Padda, Sukhmani K.
    Ramchandran, Kavitha
    Gubens, Matthew A.
    Neal, Joel W.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S731 - S731
  • [5] STAGE 1 RESULTS OF A 2-STAGE PHASE II TRIAL OF SINGLE AGENT AMRUBICIN IN PATIENTS WITH PREVIOUSLY TREATED THYMIC MALIGNANCIES
    Wakelee, Heather
    Riess, Jonathan
    Pedro-Salcedo, Melanie San
    Padda, Sukhmani
    Ramchandran, Kavitha
    Gubens, Matthew
    Neal, Joel
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : 22 - 23
  • [6] Randomized, phase II trial comparing amrubicin with topotecan in patients (pts) with previously treated small cell lung cancer (SCLC)
    Sugawara, S.
    Inoue, A.
    Yamazaki, K.
    Saijo, Y.
    Gomi, K.
    Ishimoto, O.
    Hommura, F.
    Maemondo, M.
    Suzuki, T.
    Nukiwa, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Phase II trial of amrubicin in patients with previously treated small cell lung cancer (SCLC).
    Kato, T.
    Nokihara, H.
    Ohe, Y.
    Yamamoto, N.
    Sekine, I.
    Kunitoh, H.
    Kubota, K.
    Nishiwaki, Y.
    Saijo, N.
    Tamura, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 379S - 379S
  • [8] Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II study
    Ikeda, Takaya
    Takemoto, Shinnosuke
    Senju, Hiroaki
    Gyotoku, Hiroshi
    Taniguchi, Hirokazu
    Shimada, Midori
    Dotsu, Yosuke
    Umeyama, Yasuhiro
    Tomono, Hiromi
    Kitazaki, Takeshi
    Fukuda, Masaaki
    Soda, Hiroshi
    Yamaguchi, Hiroyuki
    Fukuda, Minoru
    Mukae, Hiroshi
    THORACIC CANCER, 2020, 11 (07) : 1972 - 1978
  • [9] A phase II study of pembrolizumab for patients with previously treated advanced thymic epithelial tumor.
    Cho, Jinhyun
    Ahn, Myung-Ju
    Yoo, Kwai Han
    Lee, Hansang
    Kim, Hee Kyung
    Heo, Mi Hwa
    Hong, Joo Hyun
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] Phase II trial of pembrolizumab (P) in patients (pts) with previously-treated mesothelioma (MM).
    Desai, Arpita
    Karrison, Theodore
    Rose, Buerkley
    Pemberton, Erika
    Hill, Bianca
    Straus, Christopher M.
    Tan, Yi-Hung Carol
    Seiwert, Tanguy Y.
    Kindler, Hedy L.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345